PROGNOSIS – the German Bronchiectasis Registry

Impressively, biomedical research and resulting innovations have improved the prognosis of patients with cystic fibrosis (CF) over the past decades. While bronchiectasis is the hallmark of CF lung manifestation, there is still no approved pharmacotherapy available for the treatment of bronchiectasis not associated with CF. Consequently, bronchiectasis is considered one of the most neglected diseases in respiratory medicine, with a great lack of research and an urgent need to determine the optimal management strategies. Recently, we provided first epidemiological evidence on the burden and the prevalence of bronc…